Koļesova, OksanaEglite, JeļenaKoļesovs, AleksandrsKrumiņa, AngelikaEkšteina, IlzeMadelane, MontaViksna, Ludmila2021-04-192021-04-192019-08-01Koļesova, O, Eglite, J, Koļesovs, A, Krumiņa, A, Ekšteina, I, Madelane, M & Viksna, L 2019, 'Association of non-invasive markers of liver fibrosis with HCV coinfection and antiretroviral therapy in patients with HIV', Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences, vol. 73, no. 4, pp. 400-402. https://doi.org/10.2478/prolas-2019-00621407-009Xhttps://dspace.rsu.lv/jspui/handle/123456789/3847Publisher Copyright: © 2019 Oksana Koļesova et al., published by Sciendo 2019. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.The aim of this study was to assess the main effects and interaction between viral hepatitis C (HCV) coinfection and antiretroviral therapy (ART) by using a nonparametric ANOVA on direct and indirect markers of liver fibrosis in HIV-infected patients. The sample included 178 HIV patients aged from 23 to 65 (36% females). The following parameters were determined in blood of patients: hyaluronic acid, pro-matrix metalloproteinase-1, alanine aminotransferase, aspartate aminotransferase, and platelet count. The FIB-4 index was also calculated. The nonparametric ANOVA revealed no significant interaction between HCV coinfection and ART. This provides evidence for an independent contribution of each factor on promotion of the pathology. The results also demonstrated that the direct and indirect indicators of liver fibrosis are associated differently with the studied factors. Therefore, a combination of markers should be used for monitoring of liver fibrosis in HIV-infected patients.382368enginfo:eu-repo/semantics/openAccessALTASTFIB-4hyaluronic acidliver fibrosisnonparametric ANOVApro-MMP-13.2 Clinical medicine3.3 Health sciences1.1. Scientific article indexed in Web of Science and/or Scopus databaseGeneralSDG 3 - Good Health and Well-being/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article10.2478/prolas-2019-0062http://www.scopus.com/inward/record.url?scp=85069664164&partnerID=8YFLogxK